D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$452M |
| 2 |
Apple
AAPL
|
+$291M |
| 3 |
Schlumberger
SLB
|
+$264M |
| 4 |
Johnson & Johnson
JNJ
|
+$254M |
| 5 |
TJX Companies
TJX
|
+$221M |
Top Sells
| 1 |
Walt Disney
DIS
|
+$313M |
| 2 |
Amazon
AMZN
|
+$307M |
| 3 |
YHOO
Yahoo Inc
YHOO
|
+$285M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$205M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$194M |
Sector Composition
| 1 | Technology | 16.98% |
| 2 | Healthcare | 12.86% |
| 3 | Financials | 11.44% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Industrials | 10.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BIOL
2226
DELISTED
Biolase, Inc.
BIOL
| $214K | ﹤0.01% |
13
-1
| -7% | -$16.5K |
|
|
TIF
2227
DELISTED
Tiffany & Co.
TIF
| $214K | ﹤0.01% |
+2,242
| New | +$214K |
|
|
SSI
2228
DELISTED
Stage Stores Inc
SSI
| $214K | ﹤0.01% |
82,548
-22,218
| -21% | -$57.6K |
|
2229
Celldex Therapeutics
CLDX
$1.61B
| $213K | ﹤0.01% |
3,933
-33,750
| -90% | -$1.83M |
|
2230
Northern Trust
NTRS
$24.6B
| $213K | ﹤0.01% |
2,458
-800
| -25% | -$69.3K |
|
2231
BlackRock TCP Capital
TCPC
$611M
| $213K | ﹤0.01% |
12,246
-833
| -6% | -$14.5K |
|
2232
Minerva Neurosciences
NERV
$15M
| $212K | ﹤0.01% |
+3,267
| New | +$212K |
|
|
CERN
2233
DELISTED
Cerner Corp
CERN
| $212K | ﹤0.01% |
3,605
-201,205
| -98% | -$11.8M |
|
|
HA
2234
DELISTED
Hawaiian Holdings, Inc.
HA
| $211K | ﹤0.01% |
+4,535
| New | +$211K |
|
2235
NVE Corp
NVEC
$319M
| $210K | ﹤0.01% |
2,537
-5,338
| -68% | -$442K |
|
2236
VirnetX
VHC
$76.3M
| $209K | ﹤0.01% |
4,551
+291
| +7% | +$13.4K |
|
2237
Towne Bank
TOWN
$2.83B
| $207K | ﹤0.01% |
6,384
-7,493
| -54% | -$243K |
|
|
CPN
2238
DELISTED
Calpine Corporation
CPN
| $207K | ﹤0.01% |
18,747
+4,307
| +30% | +$47.6K |
|
2239
HealthEquity
HQY
$8.01B
| $206K | ﹤0.01% |
+4,847
| New | +$206K |
|
2240
International Seaways
INSW
$2.33B
| $206K | ﹤0.01% |
+10,764
| New | +$206K |
|
|
NEX
2241
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $206K | ﹤0.01% |
+14,401
| New | +$206K |
|
|
CBM
2242
DELISTED
Cambrex Corporation
CBM
| $206K | ﹤0.01% |
3,744
-20,968
| -85% | -$1.15M |
|
2243
Fossil Group
FOSL
$159M
| $205K | ﹤0.01% |
11,729
-84,778
| -88% | -$1.48M |
|
|
SCMP
2244
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $202K | ﹤0.01% |
18,363
-142,196
| -89% | -$1.56M |
|
2245
O-I Glass
OI
$1.99B
| $201K | ﹤0.01% |
9,884
-169,638
| -94% | -$3.45M |
|
|
BKCC
2246
DELISTED
BlackRock Capital Investment Corporation
BKCC
| $201K | ﹤0.01% |
26,596
-104,242
| -80% | -$788K |
|
|
TREC
2247
DELISTED
Trecora Resources
TREC
| $201K | ﹤0.01% |
18,073
-11,515
| -39% | -$128K |
|
|
SDRL
2248
DELISTED
Seadrill Limited Common Stock
SDRL
| $201K | ﹤0.01% |
468
+85
| +22% | +$36.5K |
|
|
PGH
2249
DELISTED
Pengrowth Energy Corporation
PGH
| $201K | ﹤0.01% |
201,400
-4,000
| -2% | -$3.99K |
|
|
OMED
2250
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $201K | ﹤0.01% |
+21,844
| New | +$201K |
|